Biocardia reports 2021 financial results and recent business highlights

Sunnyvale, calif., march 29, 2022 (globe newswire) -- biocardia®, inc. [nasdaq: bcda], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today reported financial results for the year ended december 31, 2021 and filed its annual report on form 10-k for the year ended december 31, 2021 with the securities and exchange commission. the company will also hold an update conference call at 4:30 pm et in which it will discuss business highlights. following management's formal remarks, there will be a question and answer session.
BCDA Ratings Summary
BCDA Quant Ranking